Description | TNFAIP1isacomponentoftheBCR(BACURD2)E3ubiquitinligasecomplex(Ref:SWISSPROT). |
BatchNo. | Seeproductlabel |
Unitsize | 100µg |
Antigen | Asyntheticpeptide(NKYVQLNVGGSLYYTTVRALTRHDTM)correspondingtoaregion(27-52aa)fromtheN-terminusofhumantumornecrosisfactor,alpha-inducedprotein1,endothelial(TNFAIP1). |
Sequence | NKYVQLNVGGSLYYTTVRALTRHDTM |
AntibodyType | Antiserum |
OtherNames | BTB/POZdomain-containingadapterforCUL3-mediatedRhoAdegradationprotein2;hBACURD2;BTB/POZdomain-containingproteinTNFAIP1;ProteinB12;TNFAIP1;BACURD2;EDP1; |
Accession | Q13829BACD2_HUMAN; |
Producedin | Rabbit |
Applications | Immunohistochemistry(IHC),Immunocytochemistry(ICC)andWesternBlotting(WB).Aconcentrationof0.5-1.0µg/mlisrecommendedforWB.HumanTNFAIP1hasapredictedlengthof316residuesandMWof36kDa.Aconcentrationof0.25-0.5µg/mlisrecommendedforIHCtodetecttheproteininformalinfixedandparaffinembeddedtissues.Heatmediatedantigenretrievalisrequired.Aconcentrationof0.25-0.5µg/mlisrecommendedforIHCtodetecttheproteininfrozentissues.Aconcentrationof0.25-0.5µg/mlisrecommendedforICC.Biosensisrecommendsoptimaldilutions/concentrationsshouldbedeterminedbytheenduser. |
Specificity | ThespecificityofthisantibodyhasbeenconfirmedbyWBandIHCagainsttheantigen. |
AntibodyAgainst | Tumornecrosisfactor,alpha-inducedprotein1,endothelial |
Cross-reactivity | Human;rat;predictedtoreactwithmouseduetosequencehomology; |
Blastit | Ifyouwishtousethisproductinaspeciesotherthanthosespecifiedhereandwanttodeterminetheaminoacidsequencehomologybetweentheimmunogenandthecorrespondingproteininthatspecies,simplycopytheaminoacidsequenceforthisimmunogenandtestitontheBLASTdatabasethatyoucanaccessthroughthelinkbelow.Pleasenotethatantibodiesraisedagainstsyntheticpeptidesarequiteoftenveryspecificforthatpeptide.Whatthismeansinpractiseisthatasingleaminoaciddifferencemaybeenoughtorestrictthespecificitytoaparticularmolecule.TheBLASTdatabasecanalsobeusedtocompareanyaminoacidsequencebetweenspeciesandbetweenproteins.ThefullaminoacidsequenceofthetargetproteincanbefoundbyfollowingthelinkintheAccessionfield.YoucanthensearchanyaminoacidsequenceinthetargetproteinusingtheBLASTdatabase.Whenselectingasequencetosearch,pleasechoosecarefully,asthesequenceyouchoosemaybeaprecursorratherthanthematureproteinforexample. |
BlastURL | Clickhere |
Form | Lyophilisedwith5mgBSA,0.9mgNaCl,0.2mgNa2HPO4,0.05mgThimerosal,0.05mgNaN3 |
Appearance | Lyophilizedwhitepowder |
Reconstitution | Reconstitutein100µlofsteriledistilledwatertoachieveanantibodyconcentrationof1mg/ml.Centrifugetoremoveanyinsolublematerial. |
Storage | Atleast12monthsafterpurchaseat2-4°C(lyophilizedformulations).Afterreconstitution,aliquotandstoreat-20°CforahigherstABIlity.Avoidfreeze-thawcycles |
ExpiryDate | 12monthsafterpurchase |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。